Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Domino's Pizza posted third-quarter results on October 12 and the market's verdict was swift: the stock fell 4.8% on October 13 to $296.10, down 5% over the past month, with analysts cutting targets across the board the following morning.
The analyst response was remarkable for its unanimity. Every firm that filed a note on October 14 moved its price target lower. Citigroup, Wells Fargo, RBC Capital, Baird, Morgan Stanley, B of A Securities, Mizuho, and StoneX all trimmed, though none changed their ratings. That pattern, targets cut but ratings held, tells the story cleanly: the Street has not given up on the name, but it is repricing what the business is worth in a tougher environment. Morgan Stanley moved to $345 from $357, maintaining Equal-Weight. B of A, one of the more constructive voices, cut to $410 from $455 while keeping its Buy. The mean target across analysts now sits at $356.85, implying about 20% above the current price, though that gap has narrowed considerably. Bulls argue the 99% franchised model, 75%-plus digital mix, and vertically integrated supply chain keep unit economics intact even as same-store sales disappoint. Bears counter that U.S. pizza delivery headwinds look structural, third-party platform benefits are finite, and international weakness in markets like Japan and France is compounding the pressure. Reduced U.S. development guidance of 175 openings adds to the case that near-term growth is constrained.
Options positioning sharpened noticeably into and after the print. The put/call ratio climbed to 0.914 on October 13, more than two standard deviations above its 20-day average of 0.844. That is the most defensive options setup in roughly a month and a contrast to the relatively calm picture that preceded the earnings release. Borrow conditions remain a separate story entirely: availability has eased slightly to around 966%, meaning shares available to lend still run at close to ten times the existing short position. Cost to borrow ticked up to 0.50% but remains negligible. Nothing in the lending market adds urgency to the short thesis.
Short interest itself has moved in a choppy, broadly unchanged direction. At 7.8% of the free float, it is up about 1.7% in one session but down 8.5% over the week, a pattern consistent with pre-earnings positioning being partially unwound. A month ago the figure was roughly the same level, around 7.5% to 8% of float, so bears have not added materially on the back of weak results. The ORTEX short score edged down to 47.4 from near 49 over the past week, reflecting a modest reduction in short-side pressure rather than any fresh escalation.
One ownership development is worth noting. FMR (Fidelity) filed a 13G/A in August showing a 12.4% stake, up from 10.2%, making it the largest declared holder on record. Soroban Capital, a concentrated long/short fund, holds roughly 8% as of its last filing in May. Warren Buffett's Berkshire, which had held a 9.9% stake as recently as early 2025, disclosed a complete exit in a May 2026 filing. That exit is now well established in the narrative, but Fidelity's continued build in the opposite direction gives the ownership picture a less bearish cast than the stock's performance might suggest. As with all 13D/G disclosures, stakes are as last reported and positions can change without a further filing once they fall below the 5% threshold.
Buyback data from EDGAR XBRL adds a small piece of context. The second quarter of 2026 was the largest Q2 for buyback spend in four years, at $159.5 million. At the same time, remaining buyback authorization was 44% below the year-prior level as of October 2025, so the company is running through capacity rather than expanding it. With the next earnings event not until February 23, the stock now settles into a period where the Street's revised targets and the pace of same-store sales recovery become the key variables to track.
See the live data behind this article on ORTEX.
Open DPZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
